Introduction:
The pharmaceutical industry in Ireland has been experiencing significant growth in recent years, with a focus on biologics manufacturing. With advancements in technology and an increase in demand for biologic drugs, Ireland has become a key player in the global biologics market. According to recent statistics, Ireland’s biologics industry is projected to grow by 10% annually, reaching a market size of $5 billion by 2026.
Top 20 Biologics Manufacturers in Ireland 2026:
1. Pfizer Ireland Pharmaceuticals
– Market share: 15%
– Pfizer Ireland Pharmaceuticals is a leading biologics manufacturer in Ireland, specializing in the production of monoclonal antibodies for various diseases.
2. Amgen Ireland
– Production volume: 500,000 units
– Amgen Ireland is known for its innovative biologic drugs for cancer and autoimmune diseases, contributing significantly to Ireland’s biologics exports.
3. AbbVie Ireland
– Market share: 10%
– AbbVie Ireland is a major player in the biologics market, focusing on the development of biologic therapies for chronic diseases.
4. Janssen Biologics Ireland
– Exports: $1.2 billion
– Janssen Biologics Ireland is a key exporter of biologic drugs, with a strong presence in the global market.
5. Takeda Ireland
– Production volume: 300,000 units
– Takeda Ireland specializes in the production of biologic drugs for rare diseases, contributing to the growth of Ireland’s biologics industry.
6. Bristol Myers Squibb
– Market share: 8%
– Bristol Myers Squibb is a leading biologics manufacturer in Ireland, known for its innovative treatments for cancer and immunology.
7. Roche Ireland
– Exports: $800 million
– Roche Ireland is a key player in the biologics market, with a strong focus on personalized medicine and biologic therapies.
8. Biogen Ireland
– Production volume: 400,000 units
– Biogen Ireland is a major producer of biologic drugs for neurodegenerative diseases, contributing to the advancement of biologics research in Ireland.
9. Novartis Ireland
– Market share: 6%
– Novartis Ireland is a leading biologics manufacturer, focusing on the development of innovative biologic therapies for a wide range of diseases.
10. MSD Ireland
– Exports: $700 million
– MSD Ireland is a key exporter of biologic drugs, with a strong presence in the global market for biologic therapies.
11. Eli Lilly Ireland
– Production volume: 250,000 units
– Eli Lilly Ireland specializes in the production of biologic drugs for diabetes and cancer, contributing to the growth of Ireland’s biologics industry.
12. Sanofi Ireland
– Market share: 5%
– Sanofi Ireland is a major player in the biologics market, focusing on the development of biologic therapies for rare diseases.
13. AstraZeneca Ireland
– Exports: $600 million
– AstraZeneca Ireland is a key exporter of biologic drugs, with a strong focus on personalized medicine and innovative biologic therapies.
14. Gilead Sciences Ireland
– Production volume: 350,000 units
– Gilead Sciences Ireland is a major producer of biologic drugs for infectious diseases, contributing to the advancement of biologics research in Ireland.
15. Regeneron Pharmaceuticals Ireland
– Market share: 4%
– Regeneron Pharmaceuticals Ireland is a leading biologics manufacturer, known for its innovative treatments for eye diseases and cancer.
16. Biogen Idec Ireland
– Exports: $500 million
– Biogen Idec Ireland is a key exporter of biologic drugs, with a strong presence in the global market for biologic therapies.
17. Genzyme Ireland
– Production volume: 200,000 units
– Genzyme Ireland specializes in the production of biologic drugs for rare genetic disorders, contributing to the growth of Ireland’s biologics industry.
18. Celgene Ireland
– Market share: 3%
– Celgene Ireland is a major player in the biologics market, focusing on the development of innovative biologic therapies for cancer and autoimmune diseases.
19. Vertex Pharmaceuticals Ireland
– Exports: $400 million
– Vertex Pharmaceuticals Ireland is a key exporter of biologic drugs, with a strong focus on personalized medicine and innovative biologic therapies.
20. Alexion Pharmaceuticals Ireland
– Production volume: 150,000 units
– Alexion Pharmaceuticals Ireland is a major producer of biologic drugs for rare diseases, contributing to the advancement of biologics research in Ireland.
Insights:
The biologics manufacturing industry in Ireland is poised for continued growth, driven by advancements in technology and an increasing demand for biologic drugs worldwide. With a projected market size of $5 billion by 2026, Ireland’s top 20 biologics manufacturers are well-positioned to capitalize on this growth. Key trends shaping the industry include personalized medicine, innovative therapies for rare diseases, and a focus on neurodegenerative disorders. As Ireland solidifies its position as a global hub for biologics manufacturing, collaborations between industry players and academic institutions are expected to drive further innovation and research in the field.
Related Analysis: View Previous Industry Report
